Shared Decision-Making for Implantable Cardioverter-Defibrillators: Policy Goals, Metrics, and Challenges

被引：9

作者：

Rao, Birju R. ^{[1
,2
]}

Merchant, Faisal M. ^{[3
,4
]}

Howard, David H. ^{[5
,6
]}

Matlock, Daniel ^{[7
,8
]}

Dickert, Neal W. ^{[3
,9
]}

机构：

[1] Univ Illinois, Chicago, IL 60607 USA

[2] Emory Univ, Atlanta, GA 30322 USA

[3] Emory Univ, Med, Div Cardiol, Atlanta, GA 30322 USA

[4] Emory Healthcare, Electrophysiol, Atlanta, GA USA

[5] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA

[6] Emory Univ, Dept Econ, Atlanta, GA 30322 USA

[7] Univ Colorado, Med, Boulder, CO 80309 USA

[8] Colorado Program Patient Ctr Decis, Boulder, CO 80309 USA

[9] Emory Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2021年 / 49卷 / 04期

基金：

美国国家卫生研究院; 美国医疗保健研究与质量局;

关键词：

Shared Decision-Making; Implantable Cardioverter-Defibrillator; Decision Aids; Cardiovascular Disease; Health Policy; CARE;

D O I：

10.1017/jme.2021.85

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

Shared decision-making has become a new focus of health policy. Though its core elements are largely agreed upon, there is little consensus regarding which outcomes to prioritize for policy-mandated shared decision-making.

引用

页码：622 / 629

页数：8

共 50 条

[21] Sport Participation in Patients with Implantable Cardioverter-Defibrillators
Rachel Lampert
Current Treatment Options in Cardiovascular Medicine, 2019, 21
[22] EXPERIENCES WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OF NEWER GENERATION
SEN, S
HEISEL, A
KALWEIT, G
FRIES, R
PETZOLD, T
JUNG, J
OZBEK, C
VOLKMER, I
GAMS, E
HERZ KREISLAUF, 1994, 26 (05): : 158 - 163
[23] System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients
Radbill, Andrew E.
Triedman, John K.
Berul, Charles I.
Fynn-Thompson, Francis
Atallah, Joseph
Alexander, Mark E.
Walsh, Edward P.
Cecchin, Frank
HEART RHYTHM, 2010, 7 (02) : 193 - 198
[24] Deactivation of implantable cardioverter-defibrillators: results of patient surveys
Herman, Dalibor
Stros, Petr
Curila, Karol
Kebza, Vladimir
Osmancik, Pavel
EUROPACE, 2013, 15 (07): : 963 - 969
[25] Transvenous lead performance of implantable cardioverter-defibrillators and pacemakers
Mori, Hitoshi
Kato, Ritsushi
Ikeda, Yoshifumi
Tsutsui, Kenta
Hoya, Hiroki
Tanaka, Sayaka
Iwanaga, Shiro
Nakano, Shintaro
Muramatsu, Toshihiro
Sumitomo, Naokata
Matsumoto, Kazuo
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (03): : 481 - 489
[26] Intravenous sedation for placement of automatic implantable cardioverter-defibrillators
Pinosky, ML
Reeves, ST
Fishman, RL
Alpert, CC
Dorman, BH
Kratz, JM
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (06) : 764 - 766
[27] Subcutaneous implantable cardioverter-defibrillators: Function, indications and implantation
Osswald B.
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2017, 31 (3) : 155 - 160
[28] Implantable cardioverter-defibrillators in patients with left ventricular noncompaction
Kobza, Richard
Jenni, Rolf
Erne, Paul
Oechslin, Erwin
Duru, Firat
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (04): : 461 - 467
[29] Implantable cardioverter-defibrillators: a long-term view
Wilson, D.
Shi, B.
Harding, S.
Lever, N.
Larsen, P.
INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 554 - 561
[30] Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators
Sherazi, Saadia
Zareba, Wojciech
Daubert, James P.
McNitt, Scott
Shah, Abrar H.
Aktas, Mehmet K.
Block, Robert C.
CARDIOLOGY JOURNAL, 2010, 17 (03) : 267 - 273

← 1 2 3 4 5 →